- Home
- MTZ vs DGX Comparison
MTZ vs DGX Comparison
Compare MTZ & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTZ | DGX |
|---|---|---|
| Founded | 1929 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 20.5B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | MTZ | DGX |
|---|---|---|
| Price | $232.72 | $173.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 13 |
| Target Price | ★ $231.37 | $196.69 |
| AVG Volume (30 Days) | 733.5K | ★ 886.2K |
| Earning Date | 10-30-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ 270.77 | 14.49 |
| EPS | 4.20 | ★ 8.51 |
| Revenue | ★ $13,762,473,000.00 | $10,850,000,000.00 |
| Revenue This Year | $15.48 | $12.37 |
| Revenue Next Year | $10.21 | $3.52 |
| P/E Ratio | $54.23 | ★ $20.41 |
| Revenue Growth | 12.99 | ★ 13.74 |
| 52 Week Low | $99.70 | $148.70 |
| 52 Week High | $233.14 | $197.55 |
Technical Indicators
Market Signals| Indicator | MTZ | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 63.60 | 33.70 |
| Support Level | $216.68 | $174.63 |
| Resistance Level | $225.50 | $176.37 |
| Average True Range (ATR) | 6.19 | 2.34 |
| MACD | 0.18 | -0.38 |
| Stochastic Oscillator | 82.96 | 16.87 |
Price Performance
Historical ComparisonAbout MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.